Sex differences in comorbidity at diagnosis of multiple sclerosis
暂无分享,去创建一个
Christina Wolfson | Ruth Ann Marrie | Helen Tremlett | Nathalie Jette | Scott B Patten | John Fisk | C. Wolfson | S. Patten | R. Marrie | J. Fisk | N. Jetté | H. Tremlett | L. Svenson | S. Warren | Sharon Warren | Lawrence W Svenson
[1] A. Martí,et al. Comorbidity associated with obesity in a large population: The APNA study. , 2015, Obesity research & clinical practice.
[2] R. Marrie,et al. Comorbidity delays diagnosis and increases disability at diagnosis in MS , 2009, Neurology.
[3] HELEN B. HUBERT,et al. Obesity as an Independent Risk Factor for Cardiovascular Disease: A 26‐year Follow‐up of Participants in the Framingham Heart Study , 1983, Circulation.
[4] C. Wolfson,et al. Performance of administrative case definitions for comorbidity in multiple sclerosis in Manitoba and Nova Scotia. , 2014, Chronic diseases and injuries in Canada.
[5] M. Doherty,et al. Comorbidities in patients with gout prior to and following diagnosis: case-control study , 2014, Annals of the rheumatic diseases.
[6] A. Simopoulos. Omega-3 Fatty Acids in Inflammation and Autoimmune Diseases , 2002, Journal of the American College of Nutrition.
[7] M. Holick,et al. Vitamin D and inflammation , 2014, Dermato-endocrinology.
[8] Jeffrey A. Cohen,et al. A systematic review of the incidence and prevalence of cardiac, cerebrovascular, and peripheral vascular disease in multiple sclerosis , 2015, Multiple sclerosis.
[9] L. Wilkins. The rising prevalence and changing age distribution of multiple sclerosis in Manitoba , 2011, Neurology.
[10] L. Virta,et al. Cardiovascular comorbidities antedating the diagnosis of rheumatoid arthritis , 2012, Annals of the rheumatic diseases.
[11] A. Langer-Gould,et al. Autoimmune diseases prior to the diagnosis of multiple sclerosis: a population-based case-control study , 2010, Multiple sclerosis.
[12] A. Weill,et al. Comorbidities at multiple sclerosis diagnosis , 2013, Journal of Neurology.
[13] Jeffrey A. Cohen,et al. A systematic review of the incidence and prevalence of autoimmune disease in multiple sclerosis , 2015, Multiple sclerosis.
[14] Albert W Wu,et al. Noncardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure. , 2003, Journal of the American College of Cardiology.
[15] Jeffrey A. Cohen,et al. The incidence and prevalence of psychiatric disorders in multiple sclerosis: A systematic review , 2015, Multiple sclerosis.
[16] D. Armstrong,et al. Vitamin D deficiency is associated with anxiety and depression in fibromyalgia , 2007, Clinical Rheumatology.
[17] M. T. Bhatti,et al. Fingolimod-associated macular edema , 2012, Neurology.
[18] R. Marrie,et al. Association between comorbidity and clinical characteristics of MS , 2011, Acta neurologica Scandinavica.
[19] C. Wolfson,et al. Prevalence and incidence of ischemic heart disease in multiple sclerosis: A population-based validation study. , 2013, Multiple sclerosis and related disorders.
[20] Christina Wolfson,et al. The Incidence and Prevalence of Multiple Sclerosis in Nova Scotia, Canada , 2013, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[21] J. Benito-León,et al. Health‐related quality of life and its relationship to cognitive and emotional functioning in multiple sclerosis patients , 2002, European journal of neurology.
[22] C. Wolfson,et al. Rising prevalence of vascular comorbidities in multiple sclerosis: validation of administrative definitions for diabetes, hypertension, and hyperlipidemia , 2012, Multiple sclerosis.
[23] M. Holick,et al. Vitamin D for health: a global perspective. , 2013, Mayo Clinic proceedings.
[24] Nancy Xiaonan Yu,et al. High rates of physician services utilization at least five years before multiple sclerosis diagnosis , 2013, Multiple sclerosis.
[25] E. D’Amico,et al. Frequency and severity of headache is worsened by Interferon‐β therapy in patients with multiple sclerosis , 2012, Acta Neurologica Scandinavica.
[26] R. Marrie,et al. Comorbidity increases the risk of hospitalizations in multiple sclerosis , 2015, Neurology.
[27] Jeffrey A. Cohen,et al. The incidence and prevalence of comorbid gastrointestinal, musculoskeletal, ocular, pulmonary, and renal disorders in multiple sclerosis: A systematic review , 2015, Multiple sclerosis.
[28] Jeffrey A. Cohen,et al. A systematic review of the incidence and prevalence of sleep disorders and seizure disorders in multiple sclerosis , 2015, Multiple sclerosis.
[29] D. Sin,et al. Understanding the biological differences in susceptibility to chronic obstructive pulmonary disease between men and women. , 2007, Proceedings of the American Thoracic Society.
[30] E. Ford,et al. Associations of Self-Reported Cigarette Smoking with Chronic Obstructive Pulmonary Disease and Co-Morbid Chronic Conditions in the United States , 2015, COPD.
[31] Ruth Ann Marrie,et al. The incidence and prevalence of psychiatric disorders in multiple sclerosis: A systematic review , 2015, Multiple sclerosis.
[32] H. Baumeister,et al. Psychiatric and somatic comorbidities are negatively associated with quality of life in physically ill patients. , 2005, Journal of clinical epidemiology.
[33] T. Pischon,et al. Influence of Obesity and Related Metabolic Alterations on Colorectal Cancer Risk , 2012, Current Nutrition Reports.
[34] D. Watson,et al. Population patterns of chronic health conditions, co-morbidity and healthcare use in Canada: implications for policy and practice. , 2008, Healthcare quarterly.
[35] Luis Rodrigo,et al. CD40: Novel Association with Crohn's Disease and Replication in Multiple Sclerosis Susceptibility , 2010, PloS one.
[36] C. Wolfson,et al. The Utility of Administrative Data for Surveillance of Comorbidity in Multiple Sclerosis: a Validation Study Cihr Team in the Epidemiology and Impact of Comorbidity on Mul- Tiple Sclerosis Includes , 2022 .
[37] C. Wolfson,et al. Mental comorbidity and multiple sclerosis: validating administrative data to support population-based surveillance , 2013, BMC Neurology.
[38] T. Loddenkemper,et al. Effect of continuous positive airway pressure treatment on seizure control in patients with obstructive sleep apnea and epilepsy , 2011, Epilepsia.
[39] Jeffrey A. Cohen,et al. A systematic review of the incidence and prevalence of cancer in multiple sclerosis , 2015, Multiple sclerosis.
[40] Stefan Pilz,et al. Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality-a review of recent evidence. , 2013, Autoimmunity reviews.
[41] J. Lünemann,et al. The initiation and prevention of multiple sclerosis , 2012, Nature Reviews Neurology.
[42] R. Marrie,et al. Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis , 2010, Neurology.